CompletedNCT05970510
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Medication studyAges 18–65China
Understand this study
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- BeijingSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: August 4, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 555
- Sponsor
- Luye Pharma Group Ltd.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05970510
- Official title
Show the full official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Participants With Generalized Anxiety Disorder.
Get this study by email
Recruitment & locations
CompletedBeijing
Questions about this study
Who is behind this study?
The study sponsor is Luye Pharma Group Ltd., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg, Toludesvenlafaxine Hydrochloride Sustained-release Tablet 160mg and placebo.
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to explore more studies?
Explore studiesRelated studies
A Non-randomized Controlled Trial Was Conducted to Observe the Improvement in the Level of HAMA in Patients With Generalized Anxiety Disorder During the 6-week Period of Oral Treatment With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction) Combined With Sertraline.
Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers